导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.73% | 749/4982 |
| 近一周 | -4.24% | 4808/5419 |
| 近一月 | 3.85% | 70/5423 |
| 近一季 | 11.74% | 182/5358 |
| 近半年 | -11.36% | 3827/5131 |
| 近一年 | 28.75% | 677/4733 |
| 近两年 | 119.57% | 638/4208 |
| 近三年 | 73.17% | 651/3661 |
| 成立以来 | 438.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
25.77% 12/5130 |
-22.10% 5066/5464 |
- - |
- - |
| 2025 | 63.02% 433/5130 |
16.92% 196/4624 |
2.40% 2170/4802 |
33.47% 1288/4970 |
2.01% 1286/5130 |
| 2024 | -4.49% 3163/4618 |
6.58% 295/4340 |
-6.58% 3448/4442 |
4.99% 3782/4550 |
-8.64% 4064/4618 |
| 2023 | -6.49% 676/4216 |
6.38% 735/3759 |
-9.77% 3268/3909 |
4.42% 35/4055 |
-6.69% 2820/4209 |
| 2022 | -6.22% 100/3578 |
-4.04% 92/2804 |
-0.22% 2607/3205 |
-5.56% 297/3430 |
3.71% 797/3570 |
| 2021 | -12.44% 1460/2717 |
-12.35% 1552/1745 |
-0.24% 1657/2232 |
-7.06% 1464/2560 |
7.75% 346/2708 |
| 2020 | 50.46% 603/1596 |
14.03% 28/1036 |
23.88% 530/1256 |
0.48% 1161/1472 |
6.00% 1293/1690 |
| 2019 | 100.37% 2/926 |
45.35% 30/3054 |
-2.45% 2095/3201 |
19.18% 33/939 |
18.57% 32/1014 |
| 2018 | -33.25% 485/668 |
- - |
- - |
- - |
-10.02% 1961/2977 |
| 2017 | -0.12% 385/531 |
- - |
- - |
- - |
- - |
| 2016 | -13.70% 217/455 |
- - |
- - |
- - |
- - |
| 2015 | 86.95% 26/433 |
- - |
- - |
- - |
- - |
| 2014 | 25.03% 199/432 |
- - |
- - |
- - |
- - |
| 2013 | 20.38% 130/398 |
- - |
- - |
- - |
- - |
| 2012 | 2.27% 308/459 |
- - |
- - |
- - |
- - |
| 2011 | -41.78% 392/392 |
- - |
- - |
- - |
- - |
| 2010 | 5.96% 140/335 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 银华内需精选混合(LOF) VS. 长安宏观策略混合A(740001) |